ઍડલવેઇસ મિડ કેપ ફંડ ડાયરેક્ટ ગ્રોથ એનએવી 27 ઓક્ટોબરના રોજ 1.35 % વધીને ₹118.83; 3-વર્ષનું સીએજીઆર 19.04 % પર

મુખ્ય ટેકઅવે

• Edelweiss Mid Cap Fund Direct Growth recorded a NAV of ₹118.83 on 27 October 2026 after rising 1.35% over the day.
• The fund's three-year CAGR stood at 19.04%, while its five-year annualised return was 15.54%.
• Assets under management stood at ₹19,230 crore and the Direct Growth expense ratio was 0.68%.
• CCI was the largest disclosed holding at 3.11%, followed by Federal Bank at 3.06% and Multi Commodity Exchange at 2.70%.

Edelweiss Mid Cap Fund Direct Growth recorded a NAV of ₹118.83 on 27 October 2026, marking a 1.35% one-day increase. The three-year CAGR displayed on the exact-date 5paisa card stood at 19.04%. Minimum SIP and lump-sum investments were both ₹100.

The fund's trailing return profile showed a one-year return of -2.50%, a three-year annualised return of 19.04% and a five-year annualised return of 15.54%. The MAX return shown on the page was 20.18.

The latest fund snapshot reported assets under management of ₹19,230 crore and a Direct Growth expense ratio of 0.68%. Portfolio disclosure showed CCI as the largest displayed holding at 3.11%, followed closely by Federal Bank at 3.06%. મલ્ટી કોમોડિટી એક્સચેન્જ 2.70%, સોલર ઇન્ડસ્ટ્રીઝ 2.09% અને સિટી યુનિયન બેંક 2.02% માટે જવાબદાર છે. Those five positions collectively represented 13.98% of the portfolio.

Risk metrics included an alpha of 5.25, standard deviation of 5.30, beta of 0.96 and Sharpe ratio of 0.78. The scheme's displayed exit-load terms imposed a 1% charge where units were redeemed or switched out on or before 90 days from allotment, with nil exit load after that period.

The 27 October NAV gain was larger than those recorded by several of the flexi-cap schemes in this batch, although daily movements should be viewed separately from longer-term performance. The historical three- and five-year return figures remained positive, while the latest one-year trailing return was negative.

મ્યુચ્યુઅલ ફંડ ઇન્વેસ્ટમેન્ટ બજારના જોખમોને આધિન છે, સ્કીમ સંબંધિત તમામ ડૉક્યુમેન્ટ કાળજીપૂર્વક વાંચો.